Xometry stock price target maintained at $50 by JMP on AI adoption trends

Investing.com - Citizens JMP has reiterated its Market Outperform rating and $50.00 price target on Xometry Inc (NASDAQ:XMTR), maintaining its positive outlook on the manufacturing marketplace platform. The stock has shown remarkable momentum, delivering a 171% return over the past year and currently trading near its 52-week high of $51.87. According to InvestingPro data, four analysts have recently revised their earnings estimates upward for the upcoming period.

The decision follows findings from Xometry’s inaugural Manufacturing Outlook survey, which revealed that 82% of manufacturing executives consider artificial intelligence a key growth driver for their businesses.

According to the survey highlighted by JMP, nearly half of manufacturing executives are already experiencing significant return on investment from their AI implementations.

JMP noted that AI adoption is expanding beyond initial applications into supply chain management, procurement processes, and quality control systems within the manufacturing sector.

The research firm views AI as becoming a "business-critical tool" for manufacturers, with workflows expected to become more automated and agile over time, potentially benefiting Xometry’s business model.

In other recent news, Xometry Inc. reported strong second-quarter 2025 earnings, with earnings per share reaching $0.09, significantly exceeding the forecast of $0.0439. The company’s revenue also outperformed expectations, coming in at $163 million compared to the anticipated $156.49 million. This marked a 3.87% surprise in revenue. The company’s marketplace revenue grew by 26% year-over-year, surpassing management’s guidance of 20-22%, as noted by JPMorgan, which raised its price target for Xometry to $55 while maintaining an Overweight rating. UBS also adjusted its price target to $40, citing strong Q2 performance, while maintaining a Neutral rating. Citizens JMP increased its price target to $50, highlighting that revenue and EBITDA exceeded the high end of guidance by $5.5 million and $1.9 million, respectively. These developments reflect broad-based strength across U.S. enterprises, international markets, and verticals for Xometry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.